MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,686,033 | +29.5% | 38,706 | +7.4% | 0.01% | +50.0% |
| Q2 2023 | $1,302,414 | +104.7% | 36,048 | +110.7% | 0.00% | +100.0% |
| Q1 2023 | $636,150 | -64.8% | 17,110 | -57.1% | 0.00% | -50.0% |
| Q4 2022 | $1,806,510 | -63.9% | 39,870 | -44.3% | 0.00% | -60.0% |
| Q3 2022 | $4,999,000 | -0.8% | 71,583 | -4.7% | 0.01% | +25.0% |
| Q2 2022 | $5,040,000 | +67.9% | 75,079 | +105.7% | 0.01% | +166.7% |
| Q1 2022 | $3,001,000 | +413.0% | 36,503 | +815.1% | 0.00% | – |
| Q4 2021 | $585,000 | -41.6% | 3,989 | -70.8% | 0.00% | -100.0% |
| Q1 2019 | $1,001,000 | +475.3% | 13,652 | +233.3% | 0.01% | +450.0% |
| Q4 2018 | $174,000 | +81.2% | 4,096 | +101.8% | 0.00% | +100.0% |
| Q3 2018 | $96,000 | -31.4% | 2,030 | -55.6% | 0.00% | 0.0% |
| Q1 2018 | $140,000 | +150.0% | 4,569 | -4.0% | 0.00% | 0.0% |
| Q3 2017 | $56,000 | +409.1% | 4,759 | +53.5% | 0.00% | – |
| Q2 2017 | $11,000 | -31.2% | 3,100 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | -88.1% | 3,100 | -27.2% | 0.00% | -100.0% |
| Q2 2015 | $134,000 | – | 4,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |